Apiam Animal Health Limited announced the appointment of Ms Evonne Collier as a Non-Executive Director to the Company's Board of Directors, with effect from 1 October 2022. Ms Collier joins the Apiam Board with significant Company Director and strategic leadership experience in many areas including business scale-up, commercial transformation and digital disruption. She also has considerable multinational experience across sales, marketing and Software as a Service in industries spanning pharmaceutical, animal health, MedTech, FinTech, eCommerce/Digital and consumer goods.

Ms Collier will stand for election at Apiam's AGM on 24 November 2022. Also, Mr. Mike van Blommestein has announced that Mike will retire as a Non-Executive Director of Apiam and not seek re-election when his term expires at the upcoming 2022 AGM on 24 November 2022. Mr. van Blommestein has been on the Board of Apiam since the time of the Company's Initial Public Offering in December 2015 and has been the Chair of the Remuneration and Nomination Committee throughout this period.

Ms Collier has served as a Chair and Non-Executive Director on various boards since 2011 and currently serves as a Director of 4DMedical Limited as well as a number of private and public unlisted companies. She currently serves as Non-Executive Director of global SaaS analytics company, Sage Automation (Chair of the Digital Products board), SaaS FinTech, Sniip (Remuneration and Nominations Chair), digital dental company, Curae Health (Chair), global eCommerce business, Australian Fitness Supplies (Chair) and Motorama Group Automotive Holdings (Chair of the Marketing and Digital Committee). Ms Collier was also previously Non-Executive Director of Smiles Limited and Think Childcare Limited prior to its acquisition in 2021.

Ms Collier holds a Master of Business (Marketing, Strategy and Innovation), Bachelor of Arts, Graduate Certificate of Applied Finance, and is a Graduate Member of the Australian Institute of Company Directors.